Get the Stockscreener App
0.185
4.11%
0.0073
Pre-market:
.19
0.005
+2.70%
Virax Biolabs Group Ltd stock is traded at $0.185, with a volume of 132.77K.
It is up +4.11% in the last 24 hours and down -23.55% over the past month.
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
See More
Previous Close:
$0.1777
Open:
$0.191
24h Volume:
132.77K
Relative Volume:
0.49
Market Cap:
$1.37M
Revenue:
$3,000
Net Income/Loss:
$-5.65M
P/E Ratio:
-0.1478
EPS:
-1.2521
Net Cash Flow:
$-5.88M
1W Performance:
-1.54%
1M Performance:
-23.55%
6M Performance:
-70.52%
1Y Performance:
-85.66%
1-Day Range:
$0.18
$0.191
1-Week Range:
$0.1732
$0.1959
52-Week Range:
$0.1732
$1.35
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Name
Virax Biolabs Group Ltd
Sector
Industry
Phone
-
Address
-
Compare VRAX vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.185 | 1.37M | 3,000 | -5.65M | -5.88M | -1.2521 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Stock (VRAX) Latest News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
If You Invested $1,000 in Virax Biolabs Group Ltd (VRAX) - Stock Titan
Virax Biolabs (NASDAQ: VRAX) COO discloses multiple long-dated stock options - Stock Titan
Virax Biolabs Shareholders Approve Reverse Split, New Charter and 2026 Equity Plan After Adjourned AGM - The Globe and Mail
Virax Biolabs (VRAX) backs reverse split range and 2M-share incentive plan - Stock Titan
Virax Biolabs (VRAX) CEO reports holdings in shares and options - Stock Titan
Virax Biolabs Group Ltd (VRAX) director discloses multiple option grants - Stock Titan
Virax Biolabs (VRAX) CFO Jason Davis becomes reporting insider with Form 3 - Stock Titan
Virax Biolabs (VRAX) director files initial insider ownership report - Stock Titan
Momentum Shift: What are Virax Biolabs Group Limiteds earnings expectations2026 Trading Recap & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update - Defense World
00019 Should I Buy - Intellectia AI
PRH Should I Buy - Intellectia AI
VRAX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 67.6% in February - Defense World
ONEG.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MGR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
US Market Recap: Will Virax Biolabs Group Limited benefit from sector rotationJuly 2025 Intraday Action & Community Shared Stock Ideas - baoquankhu1.vn
Volume Summary: How much upside does HSDT haveWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
TCGL Should I Buy - Intellectia AI
Day Trade: Is now the right time to enter AEISWeekly Trend Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
SKX PE Ratio & Valuation, Is SKX Overvalued - Intellectia AI
VRAX PE Ratio & Valuation, Is VRAX Overvalued - Intellectia AI
Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Nektar Therapeutics (NKTR) - The Globe and Mail
IVF Should I Buy - Intellectia AI
Exit Recap: Is Oriental Culture Holding LTD stock risky to hold nowEarnings Summary Report & Short-Term High Return Ideas - baoquankhu1.vn
Virax Biolabs Sets March 11, 2026 AGM to Vote on Reverse Share Split and New Equity Plan - The Globe and Mail
Bull Bear: Does Virax Biolabs Group Limited offer margin of safetyMarket Activity Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Exit Recap: Should I average down on PodcastOne Inc stockGap Down & Smart Investment Allocation Insights - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Virax Biolabs Group (NASDAQ:VRAX) Upgraded at Zacks Research - Defense World
Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why - Yahoo Finance
Virax Biolabs stock price target lowered to $1 at H.C. Wainwright By Investing.com - Investing.com South Africa
Virax Biolabs stock price target lowered to $1 at H.C. Wainwright - Investing.com India
Virax Biolabs secures $5 million in private placement to advance immunology research - MSN
HC Wainwright Reaffirms “Buy” Rating for Virax Biolabs Group (NASDAQ:VRAX) - Defense World
Virax Biolabs: Clinical Progress in PAIS and Extended Cash Runway Support Reiterated Buy Rating Despite Lowered Price Target - TipRanks
VRAX Analyst Forecasts - Quiver Quantitative
Why Virax Biolabs Group Limited stock is favored by top institutions - Улправда
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Wondering what's happening in today's after-hours session? - Chartmill
Virax Biolabs Releases Interim Financial Results for September 2025 - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Is Virax Biolabs Group Limited stock positioned for long term growthJuly 2025 Update & Real-Time Market Trend Scan - Улправда
Can Virax Biolabs Group Limited stock beat market expectations this quarterWeekly Market Outlook & Real-Time Sentiment Analysis - Улправда
Virax Biolabs (NASDAQ: VRAX) details 25.9M-share resale from $5M raise - Stock Titan
Virax Biolabs Group (NASDAQ:VRAX) Shares Down 11.3% – Here’s Why - Defense World
A new trading data show Virax Biolabs Group Ltd (VRAX) is showing positive returns. - Setenews
Virax Biolabs Group Ltd Stock (VRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):